Highlights d BioID of Nesprin-1a identifies centrosomal proteins at myotube nuclear envelope d Nesprin-1a-containing LINC complexes recruit Akap450 to myotube nuclear envelope d Akap450 is required for microtubule nucleation at the nuclear envelope d Microtubule nucleation at the nuclear envelope is involved in nuclear positioning
In Brief
Gimpel et al. find that LINC complexes comprising Nesprin-1a and Sun1/2 are required for the recruitment of centrosomal proteins and Akap450mediated microtubule nucleation activity to the myotube nuclear envelope. Absence of microtubule nucleation from the nucleus affects nuclear positioning in muscle cells in vitro and in computer simulations.
SUMMARY
The nucleus is the main microtubule-organizing center (MTOC) in muscle cells due to the accumulation of centrosomal proteins and microtubule (MT) nucleation activity at the nuclear envelope (NE) [1] [2] [3] [4] . The relocalization of centrosomal proteins, including Pericentrin, Pcm1, and g-tubulin, depends on Nesprin-1, an outer nuclear membrane (ONM) protein that connects the nucleus to the cytoskeleton via its N-terminal region [5] [6] [7] . Nesprins are also involved in the recruitment of kinesin to the NE and play a role in nuclear positioning in skeletal muscle cells [8] [9] [10] [11] [12] . However, a function for MT nucleation from the NE in nuclear positioning has not been established. Using the proximity-dependent biotin identification (BioID) method [13, 14] , we found several centrosomal proteins, including Akap450, Pcm1, and Pericentrin, whose association with Nesprin-1a is increased in differentiated myotubes. We show that Nesprin-1a recruits Akap450 to the NE independently of kinesin and that Akap450, but not other centrosomal proteins, is required for MT nucleation from the NE. Furthermore, we demonstrate that this mechanism is disrupted in congenital muscular dystrophy patient myotubes carrying a nonsense mutation within the SYNE1 gene (23560 G>T) encoding Nesprin-1 [15, 16] . Finally, using computer simulation and cell culture systems, we provide evidence for a role of MT nucleation from the NE on nuclear spreading in myotubes. Our data thus reveal a novel function for Nesprin-1a/Nesprin-1 in nuclear positioning through recruitment of Akap450-mediated MT nucleation activity to the NE.
RESULTS AND DISCUSSION
BioID Screen Identifies Nesprin-1a-Associated Centrosomal Proteins in Myotubes During skeletal muscle differentiation, Nesprin-1 expression switches from giant to smaller isoforms, particularly Nesprin-1a [17, 18] . Using C2C12 myoblasts that differentiate into myotubes upon serum withdrawal [19] , we confirmed the upregulation of Nesprin-1a during myogenic differentiation ( Figure 1A ). To carry out the biotin identification (BioID) screen [13, 14] , mycBirA* fused to Nesprin-1a (BioID-Nesprin-1a) was stably expressed in C2C12 cells and demonstrated to properly localize to the nuclear envelope (NE) upon doxycycline (DOX) induction ( Figures 1B and 1C) . BioID-Nesprin-1a expression was induced in the presence of biotin in proliferating C2C12 myoblasts and differentiated myotubes. Following affinity purification of biotinylated proteins on streptavidin-conjugated beads, we confirmed expression and biotinylation of BioID-Nesprin-1a and biotinylation of endogenous proteins ( Figure S1A ). Untreated cells (ÀDOX Àbiotin) and cells treated with only biotin (ÀDOX +biotin) were used as controls. Following tandem mass tag mass spectrometry and normalization to varying bait levels across samples, we identified 446 proteins preferentially associated with Nesprin-1a in myotubes compared to myoblasts, in at least two out of three experiments ( Figure 1D ; Data S1). These included known interactors, such as muscle A-kinase anchoring protein (mAkap; Akap6), kinesin light chains 1 and 2 (Klc1/2), and Kif5b [8, 20] . Nesprins, including Nesprin-1a/Nesprin-1, are anchored to the NE through interaction of its C-terminal KASH (Klarsicht/ANC-1/SYNE homology) domain with inner nuclear membrane SUN (Sad1/UNC-84) domain proteins, Sun1 and Sun2 [21] . We confirmed that Nesprin-1a/Nesprin-1 localization at the NE depends on Sun1/Sun2 ( Figure S1C ). In addition, we showed by small interfering RNA (siRNA)-mediated depletion that Klc1/2 localization at the NE depended on Nesprin-1 and both Sun1 and Sun2, as previously reported (Figures S1B-S1D) [8, 22] .
Four centrosomal proteins (Akap450, Pcm1, Cep170, and Pericentrin) were preferentially enriched in myotube BioID-Nesprin-1a samples ( Figure 1D ; Data S1). Akap450, Pcm1, Pericentrin, Cdk5rap2, and g-tubulin are centrosomal proteins reported to relocalize to the nucleus during skeletal muscle formation [1] [2] [3] . Concomitantly, microtubule (MT) nucleation activity is found at the NE, and the MT network itself is dramatically reorganized into dense bundles parallel to the long axis of differentiated myotubes [4, 23, 24] . Depletion of Nesprin-1 was previously reported to result in the loss of Pericentrin, Pcm1, and g-tubulin from myotube nuclei by an unknown mechanism [5] . Our BioID data led us to hypothesize that the muscle-specific Nesprin-1a isoform [17] is the elusive molecular receptor for centrosomal proteins and for MT nucleation activity at the NE during skeletal muscle formation. Consistently, Nesprin-1a/Nesprin-1 and Pericentrin were found in close proximity at the NE of differentiated C2C12 myoblasts in spectral demixing direct stochastic optical reconstruction microscopy (SD-dSTORM) [25, 26] with a lateral resolution of 20-35 nm ( Figure 1E ; SD-dSTORM, insets). Note that the signals for Nesprin-1a/Nesprin-1 and Pericentrin overlap when the SD-dSTORM data are rendered at the approximate resolution of a conventional wide-field microscope (Figure 1E ; wide-field, insets).
Nesprin-1a/Nesprin-1 Recruits Centrosomal Proteins to the NE Independently of Its Kinesin-1-Binding Domain
We next depleted Nesprin-1a/Nesprin-1 in C2C12 myoblasts ( Figure S2B ) and analyzed Pericentrin localization in myotubes. As expected, Pericentrin was absent from the NE and dispersed within the cytoplasm in Nesprin-1-depleted myotubes (Figure 1F) , with the loss of NE Pericentrin being similar to Pericentrin depletion (Figures 1G, S2A, and S2C). Protein levels of Pericen-trin were unaffected by Nesprin-1 depletion during myogenic differentiation ( Figure S2F ). Pericentrin and Akap450 were also absent from the NE of a CRISPR/Cas9-edited clonal C2C12 cell line lacking NE-associated Nesprin-1 (Figures 2E, 2F , S2H, and S2I; ÀDOX samples). Curiously, the centriole protein Cep170 [27] that we also identified to be enriched in myotube BioID-Nesprin-1a samples localized to the NE even in the absence of Nesprin-1 ( Figure S1E ), suggesting that Nesprin-1dependent and independent mechanisms might be involved in recruitment of centrosomal proteins to the NE.
Following co-depletion of Sun1 and Sun2, the percentage of nuclei showing Pericentrin at the NE was reduced to a similar extent as for Nesprin-1 or Pericentrin knockdown (Figures 1G, S2A, S2D, and S2E). Sun1 depletion alone somewhat reduced Pericentrin at the NE, whereas Sun2 depletion showed no effect ( Figures 1G and S2A ). Consistent with our RNAi data, Sun1 À/À ;Sun2 À/À mouse primary myoblasts differentiated to myotubes in vitro lacked Pericentrin at the NE; instead, Pericentrin was mislocalized to the cytoplasm ( Figures 1H and 1I ). This agrees with previous results demonstrating that only loss of both Sun1 and Sun2 affects Nesprin-1 nuclear localization in skeletal muscle [28] . However, Sun1 À/À myotubes appeared to have less Pericentrin at the NE than Sun2 À/À or wild-type myotubes, indicating that Sun1 might be the dominant SUN domain protein involved in Pericentrin NE recruitment during myogenic differentiation. Overall, we conclude that linker of nucleoskeleton and cytoskeleton (LINC) complexes comprising Nesprin-1a/Nesprin-1 and Sun1/2 are required for Pericentrin recruitment to the NE in myotubes.
Several NE proteins, including LINC complex components, are mutated in striated muscle diseases, like Emery-Dreifuss muscular dystrophy (EDMD) [29] [30] [31] [32] [33] . Recently, a homozygous nonsense mutation within the SYNE1 gene (23560 G>T) that encodes Nesprin-1 was identified in a congenital muscular dystrophy (CMD) patient [16] , resulting in decreased mRNA expression of both Nesprin-1 giant and Nesprin-1a [15] . We asked whether this premature stop mutation within SYNE1 affected NE localization of centrosomal proteins. First, we confirmed (C) Non-differentiated C2C12 cells stably expressing doxycycline-inducible myc-BirA*-Nesprin-1a were treated with (+DOX) or without (ÀDOX) doxycycline, fixed and stained for Nesprin-1 (green, clone 9F10), myc (red), or nuclei (DAPI, blue). The scale bar represents 20 mm. (D) Depicted are normalized quantities of proteins purified on streptavidin beads in BioID-Nesprin-1ɑ-expressing C2C12 myotubes (y axis) and myoblasts (x axis) treated with biotin. Each protein quantity is the ratio of the amount of a protein in cells treated with doxycycline (+DOX) to the amount from untreated cells (ÀDOX), as determined by tandem mass tag mass spectrometry following streptavidin affinity purification. Proteins in green are previously described binding partners of Nesprin-1, whereas proteins in red are known centrosomal proteins investigated in this study. See also Figure S1 and Data S1. (E) Dual-color SD-dSTORM image of Pericentrin (Pcnt, green) and Nesprin-1 (red, MANNES1E) [15, 18] at the nuclear surface of a differentiated C2C12 myoblast (left) and the same SD-dSTORM image rendered to the resolution of a conventional wide-field microscope (right). Insets show higher magnifications of colocalization regions (arrows). The scale bar represents 1 mm. The scale bar of insets represents 100 nm. (F) Representative epi-fluorescence images of 48 hr differentiated C2C12 myotubes, transfected with the indicated siRNAs. Cells were stained for Pericentrin (Pcnt, red), nuclei (DAPI, blue), and myosin heavy chain (MHC, green) to identify myotubes. The scale bar represents 20 mm. See also Figures S2A-S2F. (G) Quantification of Pericentrin recruitment to the NE in myotube nuclei after treatment with the indicated siRNAs. Error bars ± SD; n represents total number of nuclei from at least three independent experiments. ***p < 0.001; *p < 0.05; n.s., not statistically significant; t test. (H) Representative epi-fluorescence images of 72 hr differentiated primary myotubes from wild-type, Sun1 À/À , Sun2 À/À , or Sun1 À/À ;Sun2 À/À knockout mice, stained for Pericentrin (Pcnt, red), MHC (green), and nuclei (DAPI, blue). The scale bar represents 20 mm. that Nesprin-1 isoforms were absent from the NE of immortalized myotubes from this CMD patient (SYNE1 [23560 G>T]) but were present in a healthy control ( Figure S2G ). Next, we found that Pericentrin, Akap450, PCM1, and the cis-Golgi marker protein GM130 colocalized at the NE of healthy control myotubes (Figures 2A and 2B) . In contrast, these centrosomal proteins were mislocalized to the cytoplasm in SYNE1 (23560 G>T) patient myotubes, where they often concentrated at perinuclear regions together with mislocalized GM130-positive Golgi fragments.
These results indicate that the aggregates of centrosomal proteins observed in Nesprin-1-depleted cells are retained at perinuclear Golgi complex fragments. We next sought to ascertain whether the Nesprin-1a isoform was sufficient to recruit centrosomal proteins to the NE in nondifferentiated cells via heterologous expression of Nesprin-1a and the Pericentrin-Akap450 centrosomal targeting (PACT) domain [34] . Non-differentiated C2C12 myoblasts were cotransfected with dsRed-PACT and GFP-Nesprin-1a or GFP. Only non-differentiated myoblasts (negative for Myogenin; not shown) were examined. Remarkably, dsRed-PACT was recruited to the NE in addition to the centrosome in about 30% of GFP-Nesprin-1a-expressing C2C12 cells but never found at the NE of GFP-expressing cells ( Figures 2C and 2D ). These data suggest that Nesprin-1a can already induce NE localization of centrosomal proteins in non-differentiated cells but that additional factors might be required to trigger the full recruitment process during myogenic differentiation. To determine whether Nesprin-1a is truly sufficient for NE localization of centrosomal proteins in differentiated myotubes, we transduced the C2C12 cell line lacking NE-associated Nesprin-1 with the same doxycycline-inducible mycBirA*-Nesprin-1a construct used in the BioID experiments ( Figure 1B ) and examined Myogenin-positive cells for localization of Pericentrin and Akap450. Without doxycycline, Pericentrin and Akap450 were found within the cytoplasm in differentiated mycBirA*-Nesprin-1a-transduced CRISPR cells ( Figures 2E, 2F , S2H, and S2I). Induction of NE-localized myc-BirA*-Nesprin-1a by doxycycline led to recruitment of Pericentrin and Akap450 to the NE. Following washout of doxycycline, mycBirA*-Nesprin-1a and Pericentrin were concomitantly lost from the NE after 5-7 days ( Figure S2J ). These data strongly suggest that Nesprin-1a is necessary and sufficient for NE localization of a subset of centrosomal proteins during skeletal muscle formation. Whether Nesprin-1a fulfils this function exclusively would require more comprehensive testing of the multitude of KASH-containing Nesprin isoforms [17, 35] . These results also demonstrate that mycBirA*-Nesprin-1a used in the BioID experiments is biologically functional, thus strengthening our confidence in the physiological relevance of the BioID results.
Kinesin-1 is recruited to the NE via interaction with the LEWD kinesin-binding motif of Nesprin-1/Nesprin-2, and a WD/AA mutation in this domain disrupts the Nesprin-kinesin-1 interaction [8] . We set out to determine whether this domain was involved in the recruitment of Akap450 to the NE. We found that both wild-type and mutated Nesprin-1a (WD/AA) were competent to recruit Akap450 to the NE, when Nesprin-1 CRISPR myotubes were transduced with the respective doxycycline-inducible myc-BirA*-tagged Nesprin-1a or Nesprin-1a (WD/AA) constructs ( Figures 2G and 2H ). In contrast, the paralogous kinesin-binding Nesprin-2b, usually not expressed in C2C12 myotubes [17, 36] , was not able to recruit Akap450 to the NE ( Figure 2H ). As expected, kinesin-1 NE localization was lost in Nesprin-1 CRISPR myotubes ( Figure S2K ). However, NE localization of kinesin-1 could be rescued upon expression of Nesprin-1a and Nesprin-2b, but not Nesprin-1a (WD/AA). Thus, Akap450 recruitment to the NE occurs independently of the kinesin-binding site of Nesprin-1a and is probably mediated by a region in Nesprin-1a that is absent in Nesprin-2b.
Nesprin-1-Containing LINC Complex Recruits Akap450
to Nucleate MTs at the NE The recruitment of centrosomal proteins to the NE has been proposed to be responsible for MT nucleation from the nucleus in differentiated myoblasts and myotubes [4] . Our data suggest a requirement for LINC complexes in centrosomal protein recruitment to the NE. We thus interrogated which centrosomal components are involved in MT nucleation from the NE. We first used 3D structured illumination microscopy (3D SIM) in differentiated C2C12 myoblasts to show that Pericentrin is localized to the outer nuclear membrane (ONM) close to Nesprin-1a/Nesprin-1-containing foci from which MTs emanate ( Figure 3A ). To further explore these sites of MT nucleation, we used nocodazole to depolymerize MTs and then monitored MT regrowth in Myogenin-positive cells after nocodazole washout. Within five minutes, most of control siRNA-treated cells showed MT (H) C2C12 wild-type, untransduced Nesprin-1 CRISPR mutant cells or CRISPR mutant cells transduced with mycBirA*-Nesprin-1a (N1a), mycBirA*-Nesprin-1a with the LEWD motif mutated to LEAA (N1a [WD/AA]), or mycBirA*-Nesprin-2b (N2b) were incubated with doxycycline and differentiated for 48 hr, fixed, and stained for myosin heavy chain (MHC, green), Akap450 (red), and nuclei (DAPI, blue). The scale bar represents 10 mm. See also Figure S2K . regrowth from the NE ( Figures 3B and 3C ). Additionally, we noticed MT regrowth from Pericentrin-positive seeds within the cytoplasm. In cells transfected with Nesprin-1 siRNA, we observed a strong reduction in MT regrowth from the NE, whereas MTs still regrew from Pericentrin-positive cytoplasmic seeds. In the absence of both Sun1/2, we also detected a reduction of MT regrowth from the NE, whereas depletion of Sun1 or Sun2 alone had little or no effect on regrowth. None of these siRNA-mediated depletions had an effect on the longitudinal MT array in untreated differentiated myoblasts when compared to control siRNA conditions ( Figure S3A , untreated). Moreover, we confirmed that, in the presence of nocodazole, MTs were completely depolymerized and Pericentrin localization was unaffected after nocodazole treatment in all conditions ( Figure S3A , nocodazole). Taken together, these results confirm that LINC complexes are required for MT nucleation from the NE, but not for the longitudinal alignment of MTs.
To corroborate these findings, we examined MT nucleation from the NE using the same MT regrowth assay in SYNE1 (23560 G>T) patient cells. Wild-type myotubes predominantly nucleated MTs from the NE but also from minor PCM1-or Figure S3C ). Taken together, these results imply that Nesprin-1 occupies a central position in MT nucleation from the NE, most likely via the recruitment of key centrosomal components.
The identity of this key MT-nucleating component at the NE is currently unknown. Our BioID experiments identified two centrosomal proteins, Pericentrin and Akap450, which are known to be involved in MT nucleation at the centrosome through the recruitment of g-tubulin ring complexes (g-TuRCs) [37, 38] . We also identified Pcm1, which is thought to indirectly impact on MT organization through the recruitment of other proteins to the centrosome [39] . To determine whether any of these proteins is required for MT nucleation from the NE, MT regrowth experiments were carried out following depletion of Pericentrin, Akap450, or Pcm1 using two different siRNAs targeting each of the mRNAs. In cells treated with Pericentrin or Pcm1 siRNA, MTs regrew from nuclei to a similar extent as observed for control siRNA-treated cells (60% of Myogenin-positive cells). In contrast, in cells treated with Akap450 siRNA, MTs regrew from less than 30% of Myogenin-positive nuclei (Figures 3F  and 3G ). These data suggest that Akap450, but not Pericentrin, is the dominant receptor for MT-nucleating g-TuRC complexes at the NE. Consistently, in myofibers isolated from mouse skeletal muscle, Akap450 remained exclusively at the NE, whereas Pericentrin was also found at MT-nucleating Golgi elements [40] .
To elucidate the role of centrosomal proteins on the recruitment of other centrosomal proteins, we depleted Akap450, Pericentrin, Pcm1, and Cdk5rap2 (another pericentriolar material protein) [41] using specific siRNAs and examined their NE localization ( Figure S4A ). We found that depletion of Pericentrin, Pcm1, and Cdk5rap2 did not affect NE localization of Akap450. Pcm1 also localized to the NE independently of the other centrosomal proteins studied here. In contrast, Pericentrin NE localization was partially reduced by Pcm1 depletion as previously shown [5, 39] . Consistent with previous findings at the centrosome, Cdk5rap2 localization depended on Pericentrin [42] [43] [44] . These results further support the unique role of Akap450 on MT nucleation from the NE and suggest that the recruitment of a subset of centrosomal proteins requires interdependent interactions.
MT Nucleation from the Nucleus Is Necessary for Proper Nuclear Positioning
Correct nuclear positioning is important for muscle function, and mislocalized nuclei are often associated with muscular diseases [45] [46] [47] . The MT network, MT motor proteins, and MTassociated proteins (MAPs) have been implicated in nuclear positioning during skeletal muscle formation [8, 22, [46] [47] [48] . Furthermore, Nesprin-1 was reported to be involved in the distribution of skeletal muscle nuclei through the recruitment of kinesin-1 motor proteins to the NE in vivo and in vitro [8] [9] [10] [11] [12] 49] . However, it is unknown whether MT nucleation from the NE is also important for nuclear positioning. To confirm the role of Nesprin-1 in nuclear positioning [8] , we differentiated C2C12 cells treated with control or Nesprin-1-targeting siRNAs and determined the nuclear distribution along myotubes by calculating the nuclear spreading factor (SF), defined as the ratio between the observed and the maximal theoretical average distance between nuclei according to the myotube length. Nuclei in Nesprin-1-depleted myotubes were less spread throughout the myotube when compared to control myotubes ( Figures 4B  and 4C) . Similarly, we observed a reduction of nuclear spreading in SYNE1 (23560 G>T) patient myotubes when compared to wild-type myotubes ( Figure 4D ; Movie S1). If MT nucleation from the NE is required for nuclear positioning, then removing Akap450 should also induce nuclear clustering in myotubes. Consistently, depletion of Akap450, but not Pericentrin significantly reduced the SF (Figures 4E and 4F) . These results strongly support the hypothesis that Nesprin-1-mediated MT nucleation from the NE via Akap450 is required for nuclear positioning in myotubes.
To determine the role of MT nucleation from the NE on nuclear positioning, we developed a computational model of nuclear movement in myotubes, using the cytoskeleton simulation en-gine Cytosim [50] . All simulation parameters were set using measured values when possible or varied within reasonable ranges (Table S1 ; Figures S4B-S4D ). Briefly (see STAR Methods for details), in control situations, nuclei featured MT-nucleating complexes at the NE and MT plus-end (Kif5b) and MT minusend (dynein) directed motor proteins. Moreover, we incorporated MAP4 and the Kif5b-MAP7 complex within the myotube cytoplasm to accomplish anti-parallel MT organization and sliding [47, 51] . Using these minimal settings, we simulated nuclear movements within in silico myotubes and observed that nuclei moved dynamically and became evenly dispersed along their long axes. These movements in silico recapitulated those observed in cultured myotubes (Figures 4G, 4H , and S4E; Movie S2). Next, we removed MT nucleation activity from the NE and added it to centrosome-like structures randomly positioned in the cytoplasm, as observed in Nesprin-1-depleted myotubes in vitro. No other features were changed, including the NE localization of the plus-end motors (Kif5b). In this situation, nuclei clustered in the middle of the myotube or in small groups throughout the myotube, leading to a significantly decreased SF (Figures 4G, 4H , and S4E; Movie S2). Finally, we simulated nuclear distribution in myotubes where we removed both MT nucleation activity and plus-end motors (Kif5b) from the NE. We found that nuclei further clustered together and the SF was decreased even more, when compared to removal of MT nucleation alone (Figures 4G, 4H , and S4E; Movie S2). Thus, Nesprin-1-mediated MT nucleation from the NE via Akap450 has a role in nuclear positioning in myotubes independent of the recruitment of plus-end motor proteins to the NE. However, only the combined action of Nesprin-1-mediated MT nucleation and Kif5b/kinesin-1 recruitment to the nucleus seems to result in proper nuclear positioning in myotubes.
In this work, we identified the muscle-specific Nesprin-1a isoform to be required for the recruitment of several centrosomal proteins to the NE during skeletal muscle formation. Among the recruited centrosomal proteins, only Akap450 was involved in regulating MT nucleation from the NE. Our modeling and Akap450 depletion experiments indicated that MT nucleation is required for proper nuclear positioning in addition to NE-localized kinesin-1 motor protein activity. The finding that Akap450 recruitment is independent of kinesin-1 NE localization raises the intriguing possibility of synergistic coordination of MT nucleation with MT motor activity on individual Nesprin-1a/Nesprin-1 molecules to facilitate efficient nuclear positioning. Future work will address whether these two different Nesprin-1 activities work within the same LINC complex containing Nesprin-1a and Sun1/2 or whether this activity is segregated.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell lines and culture Mouse C2C12 myogenic precursor cells were cultivated at 37 C/5% CO 2 in Dulbecco's modified Eagle's medium (DMEM) containing 4.5 g/L D-glucose, 4 mM L-glutamine, 1 mM sodium pyruvate,10% fetal calf serum, and 100 U/ml penicillin; 100 mg/ml streptomycin. C2C12 cells are female. Cells were not authenticated. For immunofluorescence, C2C12 myoblasts were seeded on coverslips, 8-well m-slides or 96-well m-plates coated with 0.1% gelatin or Matrigel diluted 1:100 in DMEM. When C2C12 cells reached $90% confluence, they were switched to DMEM supplemented with 2% horse serum and 100 U/ml penicillin; 100 mg/ml streptomycin to induce myogenic differentiation for the indicated time points. For generating Nesprin-1 CRISPR cell lines, wild-type C2C12 were transfected overnight using Lipofectamine 3000 according to manufacturer's instructions with pX330 encoding Nesprin-1 N-and C-termini-directed sgRNAs and pEGFP-N1 in a 9:9:2 ratio. Cells with high levels of EGFP expression, representing high levels of pX330 transfection, were sorted as single cells into 96-well plates at the Singapore Immunology Network FACS facility. Loss of Nesprin-1 NE localization in clonal lines was assessed by immunofluorescence microscopy. Nesprin-1 CRISPR cell lines were cultivated and maintained as wild-type C2C12 cells as described above.
Human myoblasts from a healthy control or from a congenital muscular dystrophy patient carrying a homozygous nonsense mutation within the SYNE1 gene (nucleotide 23560 G>T) were immortalized by Kamel Mamchaoui and Vincent Mouly (Center for Research in Myology, Paris, France) via transduction with retrovirus vectors expressing hTERT and Cdk4 as described previously [15, 16] . Human myoblasts were cultivated in growth medium containing DMEM with GlutaMAX and DMEM 199 medium (4:1 ratio), supplemented with 20% FBS, 25 mg/ml bovine fetuin, 5 ng/ml recombinant human EGF, 0.5 ng/ml recombinant human FGF-basic, 5 mg/ml recombinant human insulin, 0.2 mg/ml dexamethasone, and 0.1% gentamicin. For immunofluorescence, human myoblasts were seeded on coverslips coated with Matrigel diluted 1:100 in DMEM, grown to $90% confluence and induced for differentiation by changing to Iscove's Modified Dulbecco's Medium (IMDM) with GlutaMAX, 2% horse serum, and 0.1% gentamicin.
Mouse strains and primary myoblasts
The Sun1 À/À (B6;129-Sun1 tm1.1Ktj /N RRID: MGI:3838371) and Sun2 À/À (B6;129S6-Sun2 tm1Mhan /J, JAX: 012716, RRID: MGI:3850091) mice were previously described [28, 54] and were maintained at the A*STAR Biological Resource Centre facility in accordance with the guidelines of the Institutional Animal Care and Use Committee. Primary myoblasts were obtained from E18.5 mouse embryos as Sun1 À/À Sun2 À/À double mutant mice die shortly after birth. Limb muscles were dissected away from skin and bones. Muscle tissue was digested in enzyme solution (0.5% w/v collagenase type II, 1.2 U/ml dispase, 2.5 mM CaCl 2 , 25 mM HEPES in Hanks' Balanced Salt Solution) for 30 min at 37 C [56] with gentle trituration using a plastic pipette tip every 10-15 min. Following addition of DMEM containing 10% FBS, resultant tissue slurry was filtered successively through 70 mm and 40 mm cell strainers. Cells were plated onto tissue culture plates for 1-2 hr in 37 C/5% CO 2 to allow contaminating fibroblasts to adhere. The myoblast enriched fraction was then plated onto 0.1% gelatin-coated tissue culture plates and maintained in Ham's F10 containing 20% fetal bovine serum and 10 mg/ml bFGF in 37 C/5%CO 2 . Myoblast enrichment by preplating of fibroblasts was repeated every 2-3 days until most fibroblasts were removed from the myoblast culture. Primary myoblasts were differentiated into myotubes by changing to DMEM supplemented with 2% horse serum and 100 U/ml penicillin; 100 mg/ml streptomycin. Due to the difficulty of sexing mouse embryos visually, sex of primary myoblasts derived from E18.5 embryos was not determined. 
METHOD DETAILS

Antibodies
The following primary antibodies were used for immunofluorescence and Western Blot analysis: rabbit anti-Pericentrin, mouse anti-Pericentrin, mouse anti-myosin, sarcomere MHC, mouse anti-GAPDH, mouse anti-Nesprin-1 (clone 9F10), mouse anti-Myc (clone 9E10), rabbit anti-Akap9, rabbit anti-PCM1, mouse anti-Myogenin (clone F5D), rat anti-tyrosinated-a-tubulin (clone YL1/2), rabbit anti-Sun1, rabbit anti-Sun2, rabbit anti-Kif5b, mouse anti-Cep170, mouse anti-GM130, and rabbit anti-CDK5RAP2. The mouse anti-Nesprin-1 (MANNES1E; MANNES1A), anti-Klc1/2, and anti-Pericentrin antibodies were kind gifts from Glenn E. Morris, Scott T. Brady, and Kunsoo Rhee, respectively. Details of secondary antibodies are in the Key Resources Table. siRNA/DNA transfection C2C12 cells were transfected at approximately 30% confluency with siRNA (20 or 50 nM final concentration) by addition of transfection complexes pre-formed for 20 min, containing 0.3 mL Lipofectamine RNAiMAX per pmol of siRNA in Opti-MEM medium.
The following siRNAs were used: non-targeting control (NC) siRNA#1, NC siRNA#2, NC siRNA#3, Nesprin-1 siRNA#1, Nesprin-1 siRNA#2, Nesprin-1 siRNA#3, Sun1 siRNA#1, Sun1 siRNA#2, Sun2 siRNA#1, Sun2 siRNA#2, Pericentrin (Pcnt) siRNA#1, Pcnt siRNA#2 or 1:1 mix of Pcnt siRNA#1 and #2, Akap450 siRNA#1, Akap450 siRNA#2, Pcm1 siRNA#1 and Pcm1 siRNA#2, Cdk5rap2 siRNA#1, and Cdk5rap2 siRNA#2, and their sequences are provided in the Key Resources Table and Table S2 .
Plasmids
Mouse cDNA was obtained from mouse hindlimb skeletal muscle RNA using ThermoScript RT-PCR System for First-Strand cDNA Synthesis with random hexamers. Human cDNA was obtained from HeLa cell RNA using the same kit. Nesprin-1a cDNA was obtained by PCR from mouse skeletal muscle cDNA using the following primers 5 0 -GCGCCTCGAGATGGTGGTGGCAGAG GACTTGC-3 0 and 5 0 -GCGCCTTAAGTCAGAGTGGAGGAGGACCGTT-3 0 and ligated into pcDNA3.1 with an EGFP tag following restriction digest with XhoI and AflII. pTripZ-mycBirA*-Nesprin-1a was obtained by PCR amplification of Nesprin-1a from pcDNA3.1 containing Nesprin-1a using 5 0 -AAGCTCGAGATGGTGGTGGCAGAGGACTTGC-3 0 and 5 0 -AGGCCACGCGTCCTAGGTCAG AGTGGAGGAGG-3 0 followed by restriction digestion with XhoI and MluI and ligation into pTripZ-mycBirA* [57] . GST-Nesprin-1a-326-634 comprising amino acids 326-634 of Nesprin-1a was obtained by PCR from pcDNA3.1-GFP-Nesprin-1a using the following primers: 5 0 -AAAAAGAATTCGAGCAGCTGATAGAGAAGAGCGAGC-3 0 and 5 0 -AAAAACTCGAGTCAGATGTGAGACTC GATGGTGTGGATGTC-3 0 and ligated into pGEX-4T-1 following restriction digest with EcoRI and XhoI. pTripZ-mycBirA*-Nesprin-2b was obtained by PCR of Nesprin-2b coding sequence from HeLa cell cDNA using 5 0 -GCGCCTCGAGATGTCCATGGAGCGGCG CATG-3 0 and 5 0 -GCGCACGCGTCCTAGGTCATGTGGGGGGTGGCCCATTG-3 0 , restriction digest with XhoI and MluI and ligation into pTripZ-mycBirA*. Site-directed mutagenesis of Nesprin-1a to obtain Nesprin-1a (WD/AA) was performed using the megaprimer method -the primers 5 0 -AAGCTCGAGATGGTGGTGGCAGAGGACTTGC-3 0 and 5 0 -TCGTAATCGTGGGCCGCTTCCAGGGG GATGG-3 0 were used to generate a forward megaprimer, which was used with reverse primer 5 0 -AGGCCACGCGTCCTAGGTCA GAGTGGAGGAGG-3 0 to PCR amplify mutant Nesprin-1a. Nesprin-1a (WD/AA) was then cloned into pTripZ-mycBirA* by restriction digestion with XhoI and MluI and ligation. For CRISPR-mediated gene editing, oligos encoding single guide RNA sequences targeting Nesprin-1 (N terminus: ACATCACCAATGTGATGCAG, C terminus: CCGTTGGTATATCTGAGCAT) were annealed by heating to 95 C then cooled gradually to room temperature, then ligated into BbsI-digested pX330-U6-Chimeric BB-CBh-hSpCas9 (a gift from Feng Zhang, Addgene plasmid Cat#42230) [55] .
Co-transfection of plasmids
For co-transfection of dsRed-PACT and GFP-Nesprin-1a or GFP, respectively, 8-well m-slides were coated with sterile-filtered 0.1% gelatin/ddH 2 O for 20 min at room temperature. One day prior to transfection, 9.000 C2C12 cells were seeded per well in 200 mL growth medium. When cells reached approximately 80% confluency, cell transfection was carried out using jetPrime. In brief, a total amount of 1 mg DNA was diluted in 50 mL jetPrime buffer and mixed by vortexing vigorously for 10 s. 2 mL jetPrime reagent were added, the mixture was vortexed again for 10 s and shortly spun down. After incubation for 10 min at room temperature, the transfection mix was added drop wise onto the cells which were kept in 200 mL freshly added growth medium containing serum and antibiotics. The following day, the growth medium was replaced to circumvent toxic side effects of the transfection reagent. The cells were kept for 36 hr in growth medium to ensure proper expression, fixed in 4% PFA and stained for Myogenin and DAPI.
motors (MT-MT steric interactions are not considered). Nuclei nucleate MTs, which undergo dynamic instability with no rescues. Moreover, the growth rate is reduced by force with a sensitivity of 1.5 pN and depends on the availability of tubulin monomers, for which a fixed pool is prescribed. The catastrophe rate depends on growth rate as observed in vitro [59] . MTs are nucleated horizontally, leading to their organization parallel to the long axis of the myotube, as shown by the EB1 comets angle analysis ( Figures  S4C and S4D ). MTs interact with nuclei via the dynein and kinesin motor proteins located at the NE. A given density of motor proteins is evenly distributed on nuclear surfaces. All motor proteins exert Hookean forces and move along bound MTs with a linear forcevelocity relationship. The maximum number of MTs nucleated by one nucleus has been estimated by counting the number of EB1 comets near myotube nuclei.
Experimental Design
All experiments were performed at least twice, typically 3-4 times. To ensure randomization, for quantification of cellular phenotypes, all cells meeting particular criteria (e.g., for nuclear spreading quantification, only myotubes with 3 or more nuclei were considered) in a field of view were counted. While blinding was not used in this study, where possible, automated image analysis was used. Samplesize estimation and statistical method of computation was not performed as it is relatively easy to obtain large numbers (N > 100) in cell microscopy-based experiments. Inclusion and exclusion criteria of any data or subjects is described in the methods and include quantification of only Myogenin or myosin heavy chain positive nuclei to identify differentiated myotubes, and nuclear spreading analysis on myotubes with at least 3 nuclei.
QUANTIFICATION AND STATISTICAL ANALYSIS
Quantification centrosomal proteins at the NE We counted the number of nuclei with more than 50% of Pericentrin or Akap450, respectively, at the NE in Myogenin-(MYOG)-or myosin heavy chain-(MHC)-positive cells.
Quantification MT re-growth MT re-growth was quantified by counting the number of Myogenin-positive nuclei that showed at least 50% of MT seeds at the NE.
Quantification dsRed-PACT at the NE We counted the number of Myogenin-negative cells that showed NE distribution of the dsRed-PACT construct in cells co-expressing GFP or GFP-Nesprin-1a, respectively.
Statistical Analysis
Statistical tests were performed using GraphPad Prism and are described in each figure legend. The exact value of n is indicated within the respective figure. Statistical significance is represented as follows: *** p < 0.001; ** p < 0.01, *p < 0.05; n.s., not statistically significant.
DATA AND SOFTWARE AVAILABILITY
Mass spectrometry data is provided in supplemental material as Data S1.
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